Immersive Virtual Reality Beneficial for Pain Relief in Cancer
MONDAY, April 8, 2024 (HealthDay News) — For hospitalized patients with cancer, immersive...
Read More
Hematology/Oncology
AACR: Cadonilimab Plus Chemo Beneficial for Gastric Adenocarcinoma
MONDAY, April 8, 2024 (HealthDay News) — For patients with gastric/gastroesophageal junction...
Read More
AACR: Little Benefit Seen for Cancer Drugs Given Accelerated Approval
MONDAY, April 8, 2024 (HealthDay News) — Most cancer drugs granted accelerated approval do...
Read More
AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
MONDAY, April 8, 2024 (HealthDay News) — An exosome-based liquid biopsy assay can...
Read More
Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma
WEDNESDAY, April 3, 2024 (HealthDay News) — Patients with primary cutaneous B-cell lymphomas...
Read More
MRI + Blood Test Results May Cut Unnecessary Biopsies for Prostate Cancer
TUESDAY, April 2, 2024 (HealthDay News) — Prostate biopsies may not be necessary for...
Read More
Crude Sickle Cell Birth Prevalence 28.54 per 10,000 in Non-Hispanic Blacks
MONDAY, April 1, 2024 (HealthDay News) — The crude sickle cell disease (SCD) birth...
Read More
Cures Act Tied to Quicker Release, Access of Imaging Reports
MONDAY, April 1, 2024 (HealthDay News) — Following Cures Act implementation, the time for...
Read More
Model Predicts Need for Bone Marrow Sampling in Monoclonal Gammopathy of Undetermined Significance
MONDAY, April 1, 2024 (HealthDay News) — A recently developed multivariable model can...
Read More
No Successful Malpractice Case Tied to Active Surveillance of Cancer
TUESDAY, April 2, 2024 (HealthDay News) — To date, there is no evidence of successful...
Read More
Tailored Axillary Treatment Safely Avoids Lymph Node Removal in Breast Cancer
THURSDAY, March 28, 2024 (HealthDay News) — Patients with breast cancer that has started to...
Read More
Atezolizumab + Chemo After Surgery Does Not Improve Survival for Triple-Negative Breast Cancer
THURSDAY, March 28, 2024 (HealthDay News) — Patients with triple-negative breast cancer do...
Read More
Increased Morbidity Risks Seen for Male, Female p.C282Y Homozygotes
WEDNESDAY, March 27, 2024 (HealthDay News) — Male and female p.C282Y homozygotes, including...
Read More
Follow-Up Colonoscopy Rate Low Within Six Months of Abnormal Stool Test
WEDNESDAY, March 27, 2024 (HealthDay News) — Fewer than half of adults have a follow-up...
Read More
Local Recurrence Rate Low With Radiation Boost in Breast Cancer Patients
WEDNESDAY, March 27, 2024 (HealthDay News) — For young breast cancer patients after complete...
Read More
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury
WEDNESDAY, March 27, 2024 (HealthDay News) — A simple risk score consisting of nine...
Read More
Supervised Exercise Improves Patient-Reported Outcomes for Metastatic Breast Cancer
WEDNESDAY, March 27, 2024 (HealthDay News) — Supervised exercise during palliative treatment...
Read More
MRI-Guided TULSA Effective at Five Years for Localized Prostate Cancer
MONDAY, March 25, 2024 (HealthDay News) — For the treatment of localized prostate cancer,...
Read More
CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma
THURSDAY, March 21, 2024 (HealthDay News) — For patients with recurrent glioblastoma,...
Read More
Survival 21 Percent a Year After ICU Discharge for Patients With Hematologic Malignancy
For hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49...
Read More